# Butterfly Network Jumps 21% on Compass AI Launch as Wall Street Weighs $3.25 Target Against Profit Woes

> Butterfly Network popped 21% on its Compass AI launch, spotlighting bedside ultrasound and stricter data safeguards. Interest is up, but profits lag even with decent liquidity.

- Type: AI news
- Page: https://completeaitraining.com/news/butterfly-network-jumps-21-on-compass-ai-launch-as-wall/
- Published: 2025-11-23
- Updated: 2025-11-23
- Author: Jeroen Erne
- Jobs: Healthcare
- Reading time: 2 min

### Butterfly Network's Compass AI launch shakes the healthcare sector

Butterfly Network (NYSE: BFLY) jumped 21.12% as investors responded to its Compass AI platform launch and heightened visibility at major healthcare conferences. For clinical leaders, the signal is clear: point-of-care ultrasound is pushing deeper into AI-assisted workflows, and data security is front and center.

Analyst sentiment: neutral. Momentum is improving, but profitability remains the sticking point.

#### Why this matters for healthcare teams

- AI at the bedside: The Compass AI platform aims to speed up image interpretation and standardize quality, which could support faster triage and reduce rescans.
- Compliance posture: New certifications including ISO 27001 and SOC 2 Type 2 reinforce controls around patient data-critical for purchasing committees and security reviews.
- Access and training: Broader attention at industry conferences suggests more pilots and education cycles across ED, primary care, and resource-limited settings.

For reference on these certifications, see [ISO 27001](https://www.iso.org/standard/27001?ref=completeaitraining.com) and the [AICPA SOC 2 framework](https://www.aicpa.org/interestareas/frc/assuranceadvisoryservices/sorhome.html?ref=completeaitraining.com).

#### The numbers clinicians and administrators will ask about

- Margins remain negative: EBIT margin at -89.1% and pretax margin at -128.2% signal ongoing losses despite a 43.3% gross margin.
- Liquidity is solid on paper: Current ratio 4.8 and quick ratio 3.4; cash and equivalents of $144.2M as of Sept 30.
- Growth is modest: Quarterly revenue up 5% year over year; management notes lower cash burn, though cash flow and EBITDA are still negative.
- Operational watch-outs: Receivable turnover at 3.9 hints at slower collections; price-to-sales sits at 6.63.

Translation for buyers: the company has cash to execute near term, but sustained profitability is still a hurdle.

#### Weekly update: Nov 17-Nov 21, 2025

Shares opened the week near $1.98 and closed at $2.81, with a weekly high of $3.09 on rising volume. Market chatter centered on Compass AI and recent certifications, which boosted interest across both healthcare and generalist investors.

Traders flagged $2.30 as a support area and $3.25 as a near-term resistance level in line with Craig-Hallum's target. The setup reflects improving sentiment without dismissing the company's financial strain.

#### Catalysts on the radar

- Compass AI rollout and product integrations within point-of-care workflows.
- Conference exposure driving pilots with health systems and global partners.
- Information security certifications (ISO 27001, SOC 2 Type 2) strengthening vendor review outcomes.

Industry context: Butterfly is keeping pace with AI-driven imaging trends but still trails peers on profitability. A neutral stance makes sense until revenue quality and operating efficiency show consistent improvement.

#### What hospital and clinic leaders should monitor

- Clinical impact: Time-to-image, scan quality consistency, and downstream effects on throughput in ED and outpatient settings.
- Economics: Total cost of ownership vs. cart-based alternatives, utilization rates by department, and training overhead.
- Security and compliance: Audit evidence for ISO 27001/SOC 2 controls, BAAs, and PHI handling across the AI stack.
- Collections and cash: Receivable cycle times and any continued reduction in cash burn.
- Margin path: Gross margin stability and a credible route to operating leverage.

#### Bottom line for healthcare decision-makers

Compass AI and security milestones make Butterfly Network a credible contender for AI-assisted point-of-care ultrasound programs. If you're evaluating a pilot, anchor it to measurable outcomes-scan success rate, read time, and impact on care pathways-while running a tight security and integration review.

If staff training is part of your rollout plan, you can browse role-specific AI courses here: [AI courses by job](https://completeaitraining.com/courses-by-job/).

**Disclaimer:** This is stock news, not investment advice.

---

This is the Markdown form of https://completeaitraining.com/news/butterfly-network-jumps-21-on-compass-ai-launch-as-wall/. The whole site is mapped at https://completeaitraining.com/llms.txt.
